Search results
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks· 6 days agoModerna (MRNA) beats expectations for both earnings and sales. Management reiterates guidance to record around $4 billion from product sales in 2024.
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 2 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA , and it's something market players shouldn't ignore. Our tracking of public ...
Why Earnings Season Could Be Great for Moderna (MRNA)
Zacks via Yahoo Finance· 7 days agoInvestors are always looking for stocks that are poised to beat at earnings season and Moderna, Inc....
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 6 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 6 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 5 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 5 days agoModerna experienced a substantial financial shift in the first quarter (Q1) of 2024, reporting a net loss of $1.2bn - a stark contrast to its net income...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 2 days agoToday, Moderna Inc (MRNA, Financial) experienced a stock price decline of 3.43%, yet it has seen a significant three-month gain of 28.21%. With a current Loss Per Share standing ...
Moderna Results Beat Estimates as Company Prepares for RSV Shot Launch
Barrons.com· 6 days agoThe biotech company used revenue from its Covid-19 vaccine to finance other new products.Read the...